Autonomic Nervous System, Fatigue and Intolerance to Physical Training, and Overtraining in High-Level Athletes

NCT ID: NCT01463761

Last Updated: 2013-03-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

131 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-07-31

Study Completion Date

2012-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Sports training aims to enhance an athlete's performance (overcompensation). To do that, the athlete must go through periods of fatigue and lower performance (overreaching). When the training plan is balanced, this fatigue is short and reversible.If the training load is too heavy or if recuperation periods are too short, it can lead to persistence fatigue that may only be reversible in the long term. This state of fatigue is part of the broader clinical picture of overtraining, which includes stark changes in performance as well as mood and sleep disorders. Many prediction and characterization methods based on biological markers have been evaluated, but they have not been put into practice in sports training due to obstacles such as reliability, interindividual variability and high costs. This study aims to evaluate a new approach based on the variability of an individual's heart rate (RR variability), which is a way of measuring autonomic nervous system (ASN) activity. It is non-invasive, low-cost, and has already proven useful in athlete health monitoring.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The investigators propose to describe the variation of these ANS regulation factors over a full year, in a population of high-level athletes, in order to measure changes in regulation which may be predictive of potential fatigue and intolerance to physical training, if such a syndrome came to be observed among the study group.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Athletes Training Fatigue

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

high-level athletes

High-level athlete, enrolled in a Ministry-recognized Pôle

ANS activity

Intervention Type DEVICE

This ANS activity is measured by nocturnal heart rates records with Holter ECG.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ANS activity

This ANS activity is measured by nocturnal heart rates records with Holter ECG.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* High-level athlete, enrolled in a Ministry-recognized Pôle
* Participant signed the informed consent form

Exclusion Criteria

* Confirmed current overtraining syndrome
* Known pregnancy on inclusion
* Athlete using cardio-inhibitor or cardio-accelerator drugs
Minimum Eligible Age

14 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Minister of Youth Affairs and Sports, France

OTHER_GOV

Sponsor Role collaborator

Centre Hospitalier Universitaire de Saint Etienne

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Frederic ROCHE, MD PhD

Role: PRINCIPAL_INVESTIGATOR

CHU de Saint-Etienne

Xavier BIGARD, MD PhD

Role: STUDY_CHAIR

Institut de Recherche Biomédicales des Armées

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CH Albertville Moutiers

Albertville, , France

Site Status

CHU de Besançon

Besançon, , France

Site Status

Université Paris XIII

Bobigny, , France

Site Status

CHU de Grenoble

Grenoble, , France

Site Status

CHU de Pointe à Pitre

Pointe à Pitre, , France

Site Status

CNSN Centre médical de Prémanon

Prémanon, , France

Site Status

CHU de Saint-Etienne

Saint-Etienne, , France

Site Status

CREPS Toulouse Midi Pyrénées

Toulouse, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2009-A00674-53

Identifier Type: OTHER

Identifier Source: secondary_id

0908073

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Fatigue Test With an XCo
NCT05112380 COMPLETED